PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia. It operates in three segments: Prescription Drugs, Consumer Health Products, and Export and Toll Manufacturing Services. It provides various prescription and consumer health products in antibiotic, antiparasit, antiseptic, anti-fungal, cough and cold, cardiology, central nervous system, gastro-hepatology, somatic, vitamin and food supplement, women healthcare, ear healthcare, and derma medic areas. The company also exports its products to Malaysia, Myanmar, the Philippines, Singapore, Vietnam, and Mongolia. The company was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk is a subsidiary of Blue Sphere Singapore Pte. Ltd.
Darya-Varia Laboratoria Dividend Announcement
• Darya-Varia Laboratoria announced a semi annually dividend of Rp43.00 per ordinary share which will be made payable on 2024-11-21. Ex dividend date: 2024-11-01
• Darya-Varia Laboratoria annual dividend for 2024 was Rp108.00
• Darya-Varia Laboratoria annual dividend for 2023 was Rp121.00
• Darya-Varia Laboratoria's trailing twelve-month (TTM) dividend yield is 9.24%
• Darya-Varia Laboratoria's payout ratio for the trailing twelve months (TTM) is 62.38%
• Darya-Varia Laboratoria's dividend growth over the last five years (2018-2023) was 2.49% year
• Darya-Varia Laboratoria's dividend growth over the last ten years (2013-2023) was 9.92% year
Darya-Varia Laboratoria Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-01 | Rp43.00 | semi annually | 2024-11-21 |
2024-06-24 | Rp65.00 | semi annually | 2024-07-12 |
2023-11-13 | Rp43.00 | semi annually | 2023-11-28 |
2023-07-06 | Rp78.00 | semi annually | 2023-07-21 |
2022-11-03 | Rp41.00 | semi annually | 2022-11-18 |
2022-07-07 | Rp75.00 | semi annually | 2022-07-27 |
2021-11-03 | Rp39.00 | semi annually | 2021-11-15 |
2021-06-24 | Rp73.00 | semi annually | 2021-07-16 |
2020-11-09 | Rp37.00 | semi annually | 2020-11-25 |
2020-07-15 | Rp70.00 | semi annually | 2020-08-07 |
2019-11-01 | Rp37.00 | semi annually | 2019-11-22 |
2019-06-20 | Rp70.00 | semi annually | 2019-07-12 |
2018-10-03 | Rp37.00 | semi annually | 2018-10-26 |
2018-05-16 | Rp70.00 | semi annually | 2018-06-06 |
2017-08-25 | Rp35.00 | semi annually | 2017-09-15 |
2017-06-14 | Rp65.00 | semi annually | 2017-07-07 |
2016-06-02 | Rp35.00 | semi annually | |
2015-09-15 | Rp30.00 | semi annually | |
2015-06-11 | Rp40.00 | semi annually | |
2014-06-24 | Rp22.00 | semi annually | |
2013-10-16 | Rp12.50 | semi annually | |
2013-06-26 | Rp34.50 | semi annually |
Darya-Varia Laboratoria Dividend per year
Darya-Varia Laboratoria Dividend growth
Darya-Varia Laboratoria Dividend Yield
Darya-Varia Laboratoria current trailing twelve-month (TTM) dividend yield is 9.24%. Interested in purchasing Darya-Varia Laboratoria stock? Use our calculator to estimate your expected dividend yield:
Darya-Varia Laboratoria Financial Ratios
Darya-Varia Laboratoria Dividend FAQ
Other factors to consider when evaluating Darya-Varia Laboratoria as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Darya-Varia Laboratoria stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Darya-Varia Laboratoria's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Darya-Varia Laboratoria publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Darya-Varia Laboratoria distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Darya-Varia Laboratoria are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Darya-Varia Laboratoria sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Darya-Varia Laboratoria distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Darya-Varia Laboratoria declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Darya-Varia Laboratoria's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Darya-Varia Laboratoria's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.